The increase in cancer incidence and mortality is challenging current cancer care delivery
globally, disproportionally affecting low‐and middle‐income countries (LMICs) when it …

Background The epidemiology of human papillomavirus (HPV) in women has been well
documented. Less is known about the epidemiology of HPV in men. We aim to provide …

Women are disproportionately affected by sexually transmitted infections (STIs) throughout
life. In addition to their high prevalence in women, STIs have debilitating effects on female …

Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …

Background Single-dose human papillomavirus (HPV) vaccination, if efficacious, would be
tremendously advantageous, simplifying implementation and decreasing costs. Methods We …

Objective Cancer incidence and mortality rates in Africa are increasing, yet their geographic
distribution and determinants are incompletely characterized. The present study aims to …

Background Cancer is a leading cause of disease and death in Latin America and the
Caribbean (LAC). Contemporary data on the cancer burden aims to inform effective cancer …

Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

Human papillomaviruses (HPVs) infect epithelial cells of human beings, and their replication
cycle is associated with epithelial differentiation. More than 200 genotypes of HPVs were …

Human papillomavirus (HPV), a common sexually transmitted virus infecting mucosal or
cutaneous stratified epithelia, is implicated in the rising of associated cancers worldwide …